PubMed中文版
| PubMed ID | 31564456 |
|---|---|
| 发表日期 | 2019 Oct 3 |
| 作者 | Long JM Holtzman DM |
| 文献标题 | Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. |
| 原始出处 | Cell |
| 影响因子 | 64.5 期刊引文指标 9.55 |
| PubMed ID | 36749830 |
|---|---|
| 发表日期 | 2023 Feb |
| 作者 | Vitek GE Decourt B Sabbagh MN |
| 文献标题 | Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. |
| 原始出处 | Expert opinion on investigational drugs |
| 影响因子 | 6.1 期刊引文指标 1.05 |
| PubMed ID | 37667136 |
|---|---|
| 发表日期 | 2023 Sep |
| 作者 | Self WK Holtzman DM |
| 文献标题 | Emerging diagnostics and therapeutics for Alzheimer disease. |
| 原始出处 | Nature medicine |
| 影响因子 | 82.9 期刊引文指标 14.13 |
| PubMed ID | 32840331 |
|---|---|
| 发表日期 | 2020 Aug |
| 作者 | Wong W |
| 文献标题 | Economic burden of Alzheimer disease and managed care considerations. |
| 原始出处 | The American journal of managed care |
| 影响因子 | 3.2 期刊引文指标 0.73 |
| PubMed ID | 30920929 |
|---|---|
| 发表日期 | 2019 Mar 29 |
| 作者 | Iadecola C Gottesman RF |
| 文献标题 | Neurovascular and Cognitive Dysfunction in Hypertension. |
| 原始出处 | Circulation research |
| 影响因子 | 20.1 期刊引文指标 3.93 |
| PubMed ID | 30846383 |
|---|---|
| 发表日期 | 2019 May |
| 作者 | Dewey CW Davies ES Xie H Wakshlag JJ |
| 文献标题 | Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment. |
| 原始出处 | The Veterinary clinics of North America. Small animal practice |
| 影响因子 | 1.9 期刊引文指标 0.98 |
| PubMed ID | 30020629 |
|---|---|
| 发表日期 | 2024 Jan |
| 作者 | Kumar A Gupta V Sharma S |
| 文献标题 | Donepezil. |
| 原始出处 | |
| 影响因子 |
| PubMed ID | 38095619 |
|---|---|
| 发表日期 | 2024 Oct |
| 作者 | Park J Simpson C Patel K |
| 文献标题 | Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease. |
| 原始出处 | The Annals of pharmacotherapy |
| 影响因子 | 2.9 期刊引文指标 0.53 |
| PubMed ID | 36251300 |
|---|---|
| 发表日期 | 2022 Dec 1 |
| 作者 | Pontecorvo MJ Lu M Burnham SC Schade AE Dage JL Shcherbinin S Collins EC Sims JR Mintun MA |
| 文献标题 | Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial. |
| 原始出处 | JAMA neurology |
| 影响因子 | 29 期刊引文指标 7.28 |
| PubMed ID | 38424470 |
|---|---|
| 发表日期 | 2024 Jun |
| 作者 | Mary A Mancuso R Heneka MT |
| 文献标题 | Immune Activation in Alzheimer Disease. |
| 原始出处 | Annual review of immunology |
| 影响因子 | 29.7 期刊引文指标 2.88 |
| PubMed ID | 37930677 |
|---|---|
| 发表日期 | 2023 Dec 1 |
| 作者 | Ballard C |
| 文献标题 | Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimer Disease. |
| 原始出处 | JAMA neurology |
| 影响因子 | 29 期刊引文指标 7.28 |
| PubMed ID | 28410660 |
|---|---|
| 发表日期 | 2017 May |
| 作者 | Pierce AL Bullain SS Kawas CH |
| 文献标题 | Late-Onset Alzheimer Disease. |
| 原始出处 | Neurologic clinics |
| 影响因子 | 2.4 期刊引文指标 0.76 |
| PubMed ID | 25551862 |
|---|---|
| 发表日期 | 2015 Jan-Mar |
| 作者 | Liang L Wei H |
| 文献标题 | Dantrolene, a treatment for Alzheimer disease? |
| 原始出处 | Alzheimer disease and associated disorders |
| 影响因子 | 2.1 期刊引文指标 0.68 |
| PubMed ID | 31643956 |
|---|---|
| 发表日期 | 2012 |
| 作者 | |
| 文献标题 | Alzheimer Disease Agents. |
| 原始出处 | |
| 影响因子 |
| PubMed ID | 22014689 |
|---|---|
| 发表日期 | 2011 Oct |
| 作者 | Gauthier S |
| 文献标题 | Treatment of Alzheimer disease: the past, the present, and the future. |
| 原始出处 | Canadian journal of psychiatry. Revue canadienne de psychiatrie |
| 影响因子 | 4 期刊引文指标 0.86 |
| PubMed ID | 35649652 |
|---|---|
| 发表日期 | 2022 Jun |
| 作者 | Chapleau M Iaccarino L Soleimani-Meigooni D Rabinovici GD |
| 文献标题 | The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. |
| 原始出处 | Journal of nuclear medicine : official publication, Society of Nuclear Medicine |
| 影响因子 | 9.3 期刊引文指标 2.59 |
| PubMed ID | 23558481 |
|---|---|
| 发表日期 | 2013 Apr |
| 作者 | Schneider LS |
| 文献标题 | Alzheimer disease pharmacologic treatment and treatment research. |
| 原始出处 | Continuum (Minneapolis, Minn.) |
| 影响因子 |
| PubMed ID | 27461865 |
|---|---|
| 发表日期 | 2016 Sep 1 |
| 作者 | Sterner RM Takahashi PY Yu Ballard AC |
| 文献标题 | Active Vaccines for Alzheimer Disease Treatment. |
| 原始出处 | Journal of the American Medical Directors Association |
| 影响因子 | 7.802 期刊引文指标 1.35 |
| PubMed ID | 26884898 |
|---|---|
| 发表日期 | 2015 |
| 作者 | Shi JM He X Lian HJ Yuan DY Hu QY Sun ZQ Li YS Zeng YW |
| 文献标题 | Tibetan medicine "RNSP" in treatment of Alzheimer disease. |
| 原始出处 | International journal of clinical and experimental medicine |
| 影响因子 | 0.1 期刊引文指标 0.03 |
| PubMed ID | 21671540 |
|---|---|
| 发表日期 | 2011 Jun 15 |
| 作者 | Winslow BT Onysko MK Stob CM Hazlewood KA |
| 文献标题 | Treatment of Alzheimer disease. |
| 原始出处 | American family physician |
| 影响因子 | 4 期刊引文指标 1.8 |